Evidence map›Paper›PMID 38381750›Full record

ArticlePloS one2024

Short communication: The miR-155a-5p is correlated with increased ROS and impaired apoptosis in macrophages infected by Leishmania braziliensis.

Tainã Lago, Thyago Marconi Cardoso, Alan Rocha, Edgar M Carvalho, Léa Cristina Castellucci

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tainã LagoServiço de Imunologia da Universidade Federal da Bahia, Salvador, Brazil.
Thyago Marconi CardosoInstituto Nacional de Ciência e Tecnologia em Doenças Tropicais, Salvador, Brazil.
Alan RochaLaboratório de Pesquisas Clínicas-LAPEC-Instituto Gonçalo Moniz-FIOCRUZ, Salvador, Bahia, Brazil.
Edgar M CarvalhoServiço de Imunologia da Universidade Federal da Bahia, Salvador, Brazil.ORCID 0000-0002-2697-8002
Léa Cristina CastellucciServiço de Imunologia da Universidade Federal da Bahia, Salvador, Brazil.ORCID 0000-0002-9625-2469
Universidade Federal da Bahia · BRFundação de Amparo à Pesquisa do Estado da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis, is a disease characterized by well-limited ulcerated lesions with raised borders in exposed parts of the body. miRNAs are recognized for their role in the complex and plastic interaction between host and pathogens, either as part of the host's strategy to neutralize infection or as a molecular mechanism employed by the pathogen to modulate host inflammatory pathways to remain undetected. The mir155 targets a broad range of inflammatory mediators, following toll-like receptors (TLRs) signaling. In this work, we evaluated the effects of the expression of miR155a-5p in human macrophages infected with L. braziliensis. Our results show that miR155a-5p is inversely correlated with early apoptosis and conversely, seems to influence an increment in the oxidative burst in these cells. Altogether, we spotted a functional role of the miR155a-5p in CL pathogenesis, raising the hypothesis that an increased miR-155 expression by TLR ligands influences cellular mechanisms settled to promote both killing and control of parasite density after infection.

Indexed as

Leishmania braziliensisLeishmaniasis, CutaneousMicroRNAsApoptosisHumansMacrophagesReactive Oxygen SpeciesMicroRNAsReactive Oxygen Species

Identifiers

PMID38381750
PMCPMC10880991
OpenAlexW4391993693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.